Serial #97073316
LIVE

Serial Number

97073316

Owner

CASI PHARMACEUTICALS, INC.

Attorney

Stacey J. Watson

First Use Date

Oct 9, 2019

Filing Date

Oct 13, 2021

Add to watchlist:

No watchlists yet
View on USPTO

Serial #97073316 Trademark

Serial Number: 97073316 • Registration: 6905002

Serial #97073316 is a trademark filed by CASI PHARMACEUTICALS, INC. on October 13, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

CASI PHARMACEUTICALS, INC. (11 trademarks)

Rockville, MD 20850

Entity Type: 03

Trademark Details

Filing Date

October 13, 2021

Registration Date

November 22, 2022

First Use Anywhere

October 9, 2019

First Use in Commerce

October 9, 2019

Published for Opposition

September 6, 2022

Goods & Services

Pharmaceutical research and development; development of pharmaceutical preparations and medicines; provision of scientific information via Internet portals in the field of medical research and biotechnology; Product development research and product development in the field of pharmaceutical, biological and biotechnological products; medical research and product development services in the field of treatments for cancer, cardiovascular, metabolic, inflammatory, nervous system, anti-infective, and dermatological conditions; pharmaceutical research and development of human therapeutics using gene editing; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Biochemical research and development; Biological research; Biomedical research services; Clinical research in the field of cancer; Conducting clinical trials for others in the field of cancer; Conducting early evaluations in the field of new pharmaceuticals; Genotyping services for research or analysis purposes; Laboratory research services relating to pharmaceuticals; Medical research; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research; Scientific research and development; Stem cell research; Technical research in the field of pharmaceutical studies

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 22, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 22, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 6, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 6, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 17, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 1, 2022 CNSA
ASSIGNED TO EXAMINER
Jul 18, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 4, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 3, 2021 NWOS
NEW APPLICATION ENTERED
Oct 16, 2021 NWAP